WallStreetZenWallStreetZen

NASDAQ: CPRX
Catalyst Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CPRX past earnings growth

How has CPRX's earnings growth performed historically?
Company
-16.25%
Industry
52.08%
Market
61.16%
CPRX's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CPRX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

CPRX past revenue growth

How has CPRX's revenue growth performed historically?
Company
85.9%
Industry
148.4%
Market
16.96%
CPRX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CPRX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CPRX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CPRX earnings and revenue history

Current Revenue
$398.2M
Current Earnings
$71.4M
Current Profit Margin
17.9%

CPRX Return on Equity

Current Company
19.8%
Current Industry
-63.5%
Current Market
188%
CPRX's Return on Equity (19.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CPRX announces earnings.

CPRX Return on Assets

Current Company
16.5%
Current Industry
2.9%
CPRX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CPRX Return on Capital Employed

Current Company
23.98%
Current Industry
19.5%
CPRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CPRX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CPRX$398.20M$127.65M$71.41M+280.39%+21.25%
AGIO$26.82M-$334.75M-$352.09M-22.25%N/A
SNDX$0.00-$208.40M-$209.36M-100.00%N/A
FUSN$2.07M-$85.08M-$94.90M+19.84%N/A
DNA$251.46M-$792.98M-$892.87M+46.77%N/A
View Top Biotech Stocks

CPRX earnings dates

Next earnings date
May 30, 2024

Catalyst Pharmaceuticals Earnings & Revenue FAQ

What were CPRX's earnings last quarter?

On Invalid Date, Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q4 2023 earnings per share (EPS) of $0.33, up 37.5% year over year. Total Catalyst Pharmaceuticals earnings for the quarter were $34.84 million. In the same quarter last year, Catalyst Pharmaceuticals's earnings per share (EPS) was $0.24.

If you're new to stock investing, here's how to buy Catalyst Pharmaceuticals stock.

What was CPRX's earnings growth in the past year?

As of Q2 2024, Catalyst Pharmaceuticals's earnings has grown -16.25% year over year. This is 68.33 percentage points lower than the US Biotechnology industry earnings growth rate of 52.08%. Catalyst Pharmaceuticals's earnings in the past year totalled $71.41 million.

What is CPRX's earnings date?

Catalyst Pharmaceuticals's earnings date is Invalid Date. Add CPRX to your watchlist to be reminded of CPRX's next earnings announcement.

What was CPRX's revenue last quarter?

On Invalid Date, Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q4 2023 revenue of $110.57 million up 81.98% year over year. In the same quarter last year, Catalyst Pharmaceuticals's revenue was $60.76 million.

What was CPRX's revenue growth in the past year?

As of Q2 2024, Catalyst Pharmaceuticals's revenue has grown 85.9% year over year. This is 62.5 percentage points lower than the US Biotechnology industry revenue growth rate of 148.4%. Catalyst Pharmaceuticals's revenue in the past year totalled $398.20 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.